Most advanced is tirzepatide, a GIP-GLP-1 co-agonist, which was recently approved for diabetes therapy in the US
If you have Type 2 diabetes, high blood pressure, or heart disease, losing weight with GLP-1 antagonists may help improve your overall health
29 In fact, participating providers are encouraged to purchase high-cost prescription drugs to receive more substantial discounts under 340B that effectively pad providers bottom lines
A MASLD substudy within the phase 2 obesity trial of retatrutide provided compelling evidence of hepatic benefits
These include: Exenatide (Byetta, Bydureon) One of the first GLP-1s, modest weight loss of 23%
GET STARTED FOR ONLY $149 THE CHRONOS DIFFERENCE Physician-Led Care : Youre never alone in your journey